Automation In Biopharma Industry Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theAutomation In Biopharma Industry Market?
The anticipated acceleration in the use of robots in pharmaceutical production will likely spur development in the automation sector of the biopharma industry market. Robots in this context refer to progressive automated machines and systems engineered to carry out various tasks in the creation and packaging of pharmaceutical products. Robots have found multiple applications in pharmaceutical production including secondary packaging, intralogistics, lab automation, pick and place, pharmacy process automation, and personalized medicine. These applications boost productivity, improve precision, decrease contamination risks, and enhance worker safety. For example, in September 2024, the Germany-based, non-profit professional body, International Federation of Robotics, reported that industrial robot installations in the European manufacturing industry saw an increase of 9%, setting a new record at 92,393 units. Of these installations, 80% (equating to 73,534 units) were established within the European Union, marking a 2% increase from the preceding year. As such, the rising use of robots in pharmaceutical production is predicted to bolster the growth of the automation in biopharma industry market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp
#What is the Anticipated CAGR of theAutomation In Biopharma Industry Market, and What Factors Will Drive It?
There has been significant growth in the market size of automation in the biopharma industry in past years. It is predicted to expand from $2.08 billion in 2024 to $2.2 billion in 2025, signifying a compound annual growth rate (CAGR) of 5.9%. The robust growth during the historical period was due to various factors such as the rise in complexity of biopharmaceutical procedures, the necessity for enhanced process proficiency, growth in the development and manufacturing of biologics, the demand for assurance and control of quality, and the urgency to lessen the time-to-market.
The market for automation in the biopharma industry is projected to witness robust expansion in the coming years, expecting to surge to $2.92 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. Various factors contributing to this projected growth during the forecast period include improved data integrity and documentation, the emergence of personalized medicine, the development of modular and flexible bioprocessing facilities, the progression of automation platforms, increasing demand for biosimilars, and the implementation of smart sensors and internet of things (IoT). Major trends predicted for the forecast period encompass breakthroughs in robotics and automation technologies, progress in single-use technologies, the incorporation of artificial intelligence in bioprocessing, advancements in process analytical technologies (PAT), collaborations between biopharma and tech companies, and a focus on sustainability in biopharma automation.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704
Which Cutting-Edge Market Trends Are Expected to Drive theAutomation In Biopharma Industry Market’s Growth?
The surge in technological innovations stands as a fundamental trend in the automation within the biopharma industry market. For the key players in this sector, introducing cutting-edge product technologies is a strategic move to solidify their market stance. An apt example of this progress is PerkinElmer Inc., an American firm known for its scientific solutions and technologies. In September 2022, the company rolled out the Cellaca PLX Image Cytometry System, an innovative automated cell analysis solution crafted to streamline cell and gene therapy research and development processes. This platform enables researchers to efficiently evaluate key quality aspects of cell samples such as identity, amount, and quality, through an automated process. The integrated system harmonizes image cytometer tools, software, validated consumables, and easily traceable data reporting, thus reducing the complexities associated with calibration and training.
What Are the Leading Market Players Impacting theAutomation In Biopharma Industry Market’s Growth Trend?
Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Automation In Biopharma Industry Market Driving Opportunities and Innovations?
The automation in biopharma industry market covered in this report is segmented –
1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase
Subsegments:
1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theAutomation In Biopharma Industry Market?# Market Expansion?
North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Automation In Biopharma Industry Maret 2025, By The Business Research Company:
Industrial Automation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/industrial-automation-global-market-report
Logistics Automation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/logistics-automation-global-market-report
Process Automation and Instrumentation Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
